| __timestamp | TG Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 855506000 |
| Thursday, January 1, 2015 | 43445817 | 996170000 |
| Friday, January 1, 2016 | 66489820 | 1047690000 |
| Sunday, January 1, 2017 | 96886134 | 1324625000 |
| Monday, January 1, 2018 | 153793000 | 1416476000 |
| Tuesday, January 1, 2019 | 148369000 | 1754540000 |
| Wednesday, January 1, 2020 | 151934000 | 1829537000 |
| Friday, January 1, 2021 | 198532000 | 3051100000 |
| Saturday, January 1, 2022 | 112128000 | 2540300000 |
| Sunday, January 1, 2023 | 76192000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Data in motion
In the competitive world of biotechnology, investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outpaced TG Therapeutics, Inc. in R&D spending. From 2014 to 2023, Vertex's R&D expenses surged by approximately 270%, peaking at over $3.16 billion in 2023. In contrast, TG Therapeutics saw a more modest increase of around 143%, with their highest expenditure reaching nearly $199 million in 2021.
This significant disparity highlights Vertex's aggressive strategy in pioneering new treatments and maintaining its market leadership. Meanwhile, TG Therapeutics, though smaller in scale, continues to invest steadily, reflecting its commitment to innovation in niche therapeutic areas. As the biotech landscape evolves, these investment trends underscore the importance of R&D in driving future breakthroughs and sustaining competitive advantage.
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Amgen Inc. vs TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Vertex Pharmaceuticals Incorporated or Galapagos NV: Who Invests More in Innovation?
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Amphastar Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs TG Therapeutics, Inc.
R&D Insights: How Insmed Incorporated and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs TG Therapeutics, Inc.
Comparing Innovation Spending: TG Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.